Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jelle Kylstra, Mike Ward

Premium

Atossa Genetics announced the hiring of Jelle Kylstra as its new VP of clinical research and development. Kylstra joined the company on May 19, and brings with her more than 23 years of industry experience.

Before joining Atossa, Kylstra was VP of global clinical affairs at Spectrum Pharmaceuticals. Prior to that, Kylstra held various leadership roles at AngioDynamics, Light Sciences Corp., and other firms.


BioNano Genomics announced that Mike Ward will serve as its VP of corporate development. Ward brings to the company more than two decades of experience in life sciences-related investment banking, venture capital, and private equity.

Ward comes to BioNano from Lurie Investment Fund. He has worked at various investment banks, including Leerink Partners, Credit Suisse, and others.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.